AG
TRPX

Advisor Group’s Therapix Biosciences Ltd. TRPX Stock Holding History

Advisor Group’s Portfolio TRPX Stock Details TRPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-10,000
Closed -$58K – 5144
2017
Q3 		$58K Buy
+10,000
New +$59.9K ﹤0.01% 2833

Other funds holding TRPX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return

Advisor Group's TRPX Position: Q4 2017 in Review

Advisor Group sold out of Therapix Biosciences Ltd. (TRPX) in Q4 2017, closing a stake of 10,000 shares — an estimated $58K sold.

Advisor Group first reported a position in TRPX in Q3 2017 and held it in 1 quarter. The position peaked at $58K in Q3 2017. 5 funds tracked by Wall St. Rank hold TRPX as of Q4 2017.

  • Advisor Group reported no remaining Therapix Biosciences Ltd. position as of Q4 2017 after selling out during the quarter.
  • Advisor Group sold 10,000 Therapix Biosciences Ltd. shares in Q4 2017, an estimated $58K.
  • Advisor Group first reported a position in Therapix Biosciences Ltd. in Q3 2017 and held it in 1 quarter.
  • Advisor Group's Therapix Biosciences Ltd. position peaked at $58K in Q3 2017.
  • 5 funds tracked by Wall St. Rank held Therapix Biosciences Ltd. as of Q4 2017.

Based on Advisor Group's 13F filing for Q4 2017, filed 14 Feb 2018.